Reducing contrast media dosage for pulmonary embolism CTPA in PCD-CT: a comparative study of EID-CT and PCD-CT in the era of individualized protocolling - Report - MDSpire

Reducing contrast media dosage for pulmonary embolism CTPA in PCD-CT: a comparative study of EID-CT and PCD-CT in the era of individualized protocolling

  • By

  • Lion Stammen

  • Eva J. I. Hoeijmakers

  • Thomas G. Flohr

  • Hester A. Gietema

  • Janneke Vandewall

  • Joachim E. Wildberger

  • Cécile R. L. P. N. Jeukens

  • Bibi Martens

  • October 17, 2025

  • 0 min

Share

Optimizing Contrast Media Usage in CTPA: EID-CT vs PCD-CT with Personalized Protocols

Overview

This study compares contrast media (CM) dose optimization in computed tomography pulmonary angiography (CTPA) for pulmonary embolism (PE) detection using energy-integrating detector CT (EID-CT) and photon-counting detector CT (PCD-CT). It evaluates the feasibility of reducing CM doses while maintaining diagnostic image quality (IQ) through personalized protocols adapting to total body weight (TBW) and tube voltage (kV).

Background

CTPA is the gold standard for diagnosing PE due to its high sensitivity and specificity. Iodinated contrast media are essential for visualizing pulmonary arteries but carry risks such as contrast-induced acute kidney injury, especially in patients with renal insufficiency. Advances in CT technology, including PCD-CT, offer improved image contrast and noise reduction, potentially allowing for lower CM doses. Personalized CM protocols adapting to patient TBW and kV settings have been shown to optimize CM usage while preserving image quality.

Data Highlights

The study retrospectively analyzed consecutive CTPA scans from a third-generation dual-source EID-CT and a first-generation dual-source PCD-CT, including adult patients scanned solely for PE exclusion. EID-CT used automatic kV adaptation (70–120 kV) with TBW- and kV-adapted CM protocols, while PCD-CT used a fixed 120 kV with TBW-adapted CM and virtual monoenergetic image reconstruction at 55 keV. Both scanners employed iterative reconstruction techniques optimized for vascular imaging. Radiation dose metrics and CM injection parameters were standardized and recorded.

Key Findings

  • PCD-CT enables reconstruction of virtual monoenergetic images at low keV (55 keV), enhancing iodine contrast-to-noise ratio compared to EID-CT.
  • Using PCD-CT with a fixed 120 kV and TBW-adapted CM protocol allows for CM dose reduction while maintaining diagnostic image quality for PE detection.
  • EID-CT protocols adapt both kV and CM dose to patient morphology, following the 10-to-10 rule, achieving homogenous attenuation and optimized CM use.
  • PCD-CT eliminates electronic noise below the photon counting threshold, resulting in reduced image noise and improved contrast compared to EID-CT.
  • Personalized CM protocols based on TBW and kV settings contribute to minimizing CM dose, reducing risks of CI-AKI and environmental impact.

Clinical Implications

Implementing PCD-CT with TBW-adapted CM dosing and low-keV virtual monoenergetic imaging can reduce contrast media usage without compromising diagnostic confidence in PE detection. Personalized CM protocols that consider patient weight and scanner technology optimize image quality and patient safety, particularly in those at risk for renal injury. These strategies also support resource conservation and environmental sustainability in clinical practice.

Conclusion

PCD-CT technology combined with personalized CM protocols offers a promising approach to reduce contrast media dose in CTPA for pulmonary embolism while maintaining high diagnostic image quality. This advancement supports safer, more efficient, and environmentally conscious imaging practices.

References

  1. Various Authors/Multiple Years -- Foundational and recent studies on CTPA, CM protocols, and CT technology

Original Source(s)

Related Content